Emergent BioSolutions
EBS
#8180
Rank
A$0.49 B
Marketcap
A$9.68
Share price
-5.68%
Change (1 day)
-50.55%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): -A$0.14 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are A$0.74 Billion. In 2025 the company made an earning of A$0.20 Billion, an increase over its 2024 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.14 Billion-166.57%
2025 A$0.20 B-297.64%
2024 -A$0.11 Billion-88.82%
2023 -A$0.92 Billion242.73%
2022 -A$0.27 Billion-153.8%
2021 A$0.49 B-20.43%
2020 A$0.62 B278.02%
2019 A$0.16 B27.11%
2018 A$0.12 B-27.12%
2017 A$0.17 B17.21%
2016 A$0.15 B0.45%
2015 A$0.15 B73.51%
2014 A$87.13 M41.36%
2013 A$61.64 M35.2%
2012 A$45.59 M0.4%
2011 A$45.41 M-56.46%
2010 A$0.10 B76.73%
2009 A$59.01 M32.94%
2008 A$44.39 M-5.62%
2007 A$47.03 M
2005 A$68.1 M269.89%
2004 A$18.41 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$9.81 B-7,362.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.93 B-8,186.23%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$11.21 B-8,396.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-A$16.64 Million-87.69%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
-A$15.84 Million-88.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.47 Billion 242.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.28 B-1,787.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel